Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Luxembourg?
GlobalGov holds 20 pharmaceuticals records from 12 distinct buying organisations in Luxembourg. The most frequent publishers are Ville de Luxembourg - Service Canalisation (3 records); Administration des Ponts et Chaussées, Division de la voirie de Diekirch (2 records); Administration des Ponts et Chaussées, Division des travaux neufs (2 records); Division des travaux neufs (2 records); Luxembourg Institute of Health (2 records); Administration des Ponts et Chaussées - Division de la voirie de Luxembourg (1 record). Between them the 6 largest account for 60% of everything published, so buying here is concentrated in a few authorities.
| Buying organisation | Records | Share |
|---|---|---|
| Ville de Luxembourg - Service Canalisation | 3 | 15% |
| Administration des Ponts et Chaussées, Division de la voirie de Diekirch | 2 | 10% |
| Administration des Ponts et Chaussées, Division des travaux neufs | 2 | 10% |
| Division des travaux neufs | 2 | 10% |
| Luxembourg Institute of Health | 2 | 10% |
| Administration des Ponts et Chaussées - Division de la voirie de Luxembourg | 1 | 5.0% |
How long do bidders get to respond to pharmaceuticals tenders in Luxembourg?
Across the 8 Luxembourg pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 43 days. A quarter of them allowed 36 days or fewer and a quarter stayed open for more than 57. Not one of them closed within a fortnight of being published, so the window on this market is consistently workable.
How often are pharmaceuticals tenders published in Luxembourg?
Luxembourg published 2 notices in this category in the last twelve months. Over the last three years there were 10, spread across 16 separate months of activity since 31 October 2019. June is historically the busiest month. No new notice has been published in this category since 26 May 2026, 128 days ago, so treat the figures above as a record of the market rather than as this week's pipeline.
How does Luxembourg compare with other pharmaceuticals markets?
Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Luxembourg ranks 39th by number of records. The largest is Germany (4,115 records against 20 here). Within Luxembourg itself, pharmaceuticals is the 34th largest of the 34 procurement categories tracked here.
Where do the Luxembourg pharmaceuticals records on this page come from?
These 20 records are collected from 1 official source: TED (20). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Most recent Pharmaceuticals tenders in Luxembourg
None of these are open for bids now — they are the most recent records GlobalGov holds for this market, kept here so the shape of a typical pharmaceuticals notice in Luxembourg is visible. Set an alert to be told when the next one opens.
Other procurement categories in Luxembourg
Civil ConstructionManagement ConsultingArchitecture and EngineeringRoads and Highways InfrastructureSoftware DevelopmentVehicles and FleetIT ConsultingRenovation RehabilitationSite PreparationWaste ManagementBuilding ConstructionIct EquipmentBuilding MaterialsHospital ConstructionVehicle MaintenanceOffice FurnitureStaffing AugmentationFacilities and CleaningFinancial AdvisoryMedical EquipmentFuel SupplyGround TransportTelecommunicationsCatering ServicesScientific ResearchLaboratory EquipmentFood Aid and NutritionAudit and AccountingFreight and LogisticsUniforms ClothingElectrical InstallationResearch & DevelopmentCommunity Development
Pharmaceuticals procurement in other markets
GermanyUnited StatesItalyPolandFranceSpainRomaniaUnited KingdomSwedenCroatiaCzech RepublicNetherlands
Never Miss a Luxembourg Government Contract
Finding Luxembourg tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial